Murck-Neuroscience LLC was founded as a consulting and drug development company by Prof. Harald Murck. His team has deep expertise in clinical trial design and conduct. His affiliation at the Philipps-University Marburg allowed him to generate data, which led to a US patent in March 2020. A European patent is pending. A self-funded proof of concept trial was completed in 2020. A proof of concept placebo controlled trial with the product is ongoing ClinicalTrails. Close collaboration with European and US experts gives Murck-Neuroscience LLC the expertise to develop the anticipated first in class treatment for patients with depression.